Risk for cardiovascular disease in Japanese patients with rheumatoid arthritis: a large-scale epidemiological study

Kunihiko Tanaka1, Kenji Hamada1, Terumi Nakayama1

  • 1Drug Safety Division, Chugai Pharmaceutical Co. Ltd., 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo, 103-8324 Japan.

Springerplus
|August 2, 2016
PubMed

Insights

Japanese patients with rheumatoid arthritis (RA) face a significantly higher risk of cardiovascular disease (CVD). Systemic inflammation, indicated by C-reactive protein (CRP), may also contribute to this increased CVD risk.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory disease.
  • Cardiovascular disease (CVD) is a major concern in RA patients.
  • Understanding CVD risk in Japanese RA patients is crucial.

Purpose of the Study:

  • To investigate the risk of cardiovascular disease (CVD) in Japanese patients diagnosed with rheumatoid arthritis (RA).
  • To explore the association between systemic inflammation markers and CVD risk in RA patients.

Main Methods:

  • Utilized a Japanese health insurance claims database (Medical Data Vision) from April 2011 to March 2014.
  • Identified 8658 RA patients using ICD-10 codes and anti-RA drug history.
  • Calculated CVD incidence rate ratios (IRR) comparing RA patients to osteoarthritis patients, analyzing risk factors with Cox models.

Main Results:

  • RA patients exhibited a significantly higher risk for total CVD (IRR 2.12), ischemic heart disease (IRR 2.16), heart failure (IRR 2.34), and stroke (IRR 1.68) compared to osteoarthritis.
  • A trend suggested increased cardiovascular risk with higher baseline C-reactive protein (CRP) levels, though not statistically significant (HR 1.43).

Conclusions:

  • Japanese RA patients have an elevated risk of developing cardiovascular diseases.
  • Systemic inflammation appears to be associated with an increased risk of CVD in rheumatoid arthritis patients.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
469
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
903
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
757
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
426
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
653
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798